 intervention (from the ARMYDACIN [atorvastatin for reduction of myocardial damage
during angioplasty-contrast-induced nephropathy] trial.
Am J Cardiol 2011;108:1-7.
135. Leoncini M, Toso A, Maioli M, Tropeano F, Badia T, Villani S,
et al. Early high-dose rosuvastatin and cardioprotection in
the